Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sberbank, rebranded as Sber, is a Russian majority state-owned financial services company that has expanded into a comprehensive digital ecosystem, including a significant presence in healthcare. Through its subsidiary SberHealth, the company provides a leading telemedicine platform that offers online consultations, appointment scheduling, and remote patient monitoring. Sber also operates SberMedAI, which focuses on developing artificial intelligence solutions for medical diagnostics, such as AI-assisted analysis of CT scans and ECGs. During the COVID-19 pandemic, Sberbank played a critical role in the financial and logistical support for the production of the Sputnik V vaccine. The company's healthcare initiatives leverage its vast technological infrastructure and data analytics capabilities to modernize medical services in Russia. Sber's integrated approach aims to combine financial services with digital health tools to create a seamless user experience for patients and providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sberbank.